Ruth Eichner - Center for Translational Cancer Research, Technical University of Munich

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

SPPL3 and its substrate glycosyltransferases regulate the N-glycosylation of SLC3A2 and alter the affinities of anti-SLC3A2 immunotherapies in AML

C. Buehring-Uhle, P. Smit, A. Negraschus,V. Morath, U. Goldmann, A. Papadopoulou, M. Heider, J. Riviere, K. Goetze,L. Heinz, R. Fluhrer, M. Moser,

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022)

引用0浏览0引用

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Jacob Stroh, Anja Seckinger,Michael Heider, Martina Rudelius,Ruth Eichner, Markus Schick,Jolanta Slawska, Martina Emde-Rajaratnam,Hans Salwender,Uta Bertsch, Hartmut Goldschmidt,Katja Weisel,

Blood Advances（2022）

引用5浏览0WOS引用

Retrospective single center analysis of alpha 1 antitrypsin for steroid-refractory acute graft-versus-host-disease of the gut after multiple lines of pretreatment

K. Nickel, K. Braitsch,R. Eichner, K. Koch,I. Miller, L. Osswald, F. Bassermann, P. Herhaus, M. Verbeek

BONE MARROW TRANSPLANTATIONno. SUPPL 1 (2022)

引用0浏览0引用

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth,Tea Pemovska,Gregory I Vladimer,Günther Bayer,Michael Bergmann,Sandra Eder,Ruth Eichner, Martin Erl,Harald Esterbauer,Ruth Exner,Verena Felsleitner-Hauer,Maurizio Forte,

CANCER DISCOVERY（2022）

引用56浏览0WOS引用

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma

Michael Heider,Ruth Eichner,Jacob Stroh,Volker Morath,Anna Kuisl,Jana Zecha,Jannis Lawatscheck,Kheewoong Baek,Anne-Kathrin Garz,Martina Rudelius,Friedrich-Christian Deuschle,Ulrich Keller,

Molecular Cell（2021）

引用39浏览0WOS引用

MCT1 as molecularly validated predictive marker for lenalidomide-maintenance therapy in multiple myeloma

J. Stroh,A. Seckinger,M. Heider,R. Eichner,M. Schick, J. Slawska,M. Emde,H. Salwender,U. Bertsch,H. Goldschmidt,K. Weisel,C. Scheid,

BLOOD（2020）

引用1浏览0WOS引用

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit In Advanced Aggressive Hematological Malignancies: Final Evaluation Of The Open Label, Single Arm Exalt Trial

Christoph Kornauth,Tea Pemovska, Gregory Ian Vladimer,Günther Bayer,Michael Bergmann,Sandra Eder,Ruth Eichner,Harald Esterbauer,Ruth Exner,Verena Felsleitner-Hauer,Maurizio Forte,Alexander Gaiger,

BLOOD（2020）

引用1浏览0引用

Identification of novel interactors of CD147/MCT1 as mediators of resistance to immunomodulatory drugs in multiple myeloma

A. Kuisl,R. Eichner,S. Klaeger,V. Fernandez-Saiz, B. Kuester,F. Bassermann

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用0浏览0引用

The IMiD target Cereblon determines transmembrane protein quality control via the HSP90-AHA1 axis

M. Heider,R. Eichner, J. Stroh, A. Kuisl, J. Lawatschek,J. Zecha,M. Rudelius, A. -K. Garz,L. Jacobs, S. Lemeer, C. Peschel,U. Keller,

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用0浏览0引用

Hematopoietic lineages are characterized by specific solute carrier co-expression patterns

R. Eichner, V. Sedlyarov, A. Cesar-Razquin, G. Superti-Furga

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn